NGM · Financial Statements

EyePoint, Inc. (EYPT) Financial Statements

$0.40 NGM: EYPT Market Cap $33.91M

EyePoint, Inc. most recently reported annual revenue of $31.0M, a net loss of $232.0M. Revenue declined at an average annual rate of 1.8% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

EyePoint, Inc.: Revenue rose from $8.0M in 2016 to $31.0M in 2025, a change of +287.5% over 9 years; net profit was positive in 0 of 10 reported years; operating margin moved from -240.1% to -776.0%, a shift of -535.8 percentage points; the most recent year shows a net loss of $232.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$8.0M$3.0M$6.0M$20.0M$34.0M$37.0M$41.0M$46.0M$43.0M$31.0M
Operating Expenses$26.0M$29.0M$55.0M$68.0M$72.0M$92.0M$141.0M$121.0M$189.0M$275.0M
Operating Profit$-18.0M$-26.0M$-49.0M$-48.0M$-37.0M$-55.0M$-100.0M$-75.0M$-146.0M$-243.0M
Operating Margin-240.1%-887.3%-838.8%-235.0%-108.3%-149.6%-240.7%-163.1%-337.1%-776.0%
Other Income$0$-27.0M$-40.0M$-9.0M$-8.0M$-3.0M$-3.0M$4.0M$15.0M$12.0M
Interest$0$1.0M$1.0M$6.0M$7.0M$5.0M$3.0M$1.0M$0$0
Depreciation$1.0M$1.0M$3.0M$3.0M$3.0M$3.0M$2.0M$0$2.0M$2.0M
Profit Before Tax$-18.0M$-53.0M$-89.0M$-57.0M$-45.0M$-58.0M$-102.0M$-71.0M$-131.0M$-232.0M
Tax$0$0$0$0$0$0$0$-120,000$-70,000$-120,000
Net Profit$-18.0M$-53.0M$-53.0M$-57.0M$-45.0M$-58.0M$-102.0M$-71.0M$-131.0M$-232.0M
EPS$-5.20$-11.50$-11.50$-5.44$-3.54$-2.03$-2.74$-1.82$-2.32$-3.17
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$15.0M$14.0M$12.0M$9.0M$11.0M$12.0M$24.0M$5.0M$1.0M$1.0M$1.0M$1.0M
Operating Expenses$30.0M$30.0M$45.0M$44.0M$43.0M$57.0M$73.0M$68.0M$63.0M$71.0M$88.0M$98.0M
Operating Profit$-14.0M$-16.0M$-33.0M$-35.0M$-33.0M$-45.0M$-49.0M$-62.0M$-62.0M$-70.0M$-87.0M$-97.0M
Operating Margin-94.7%-116.6%-285.2%-364.5%-311.2%-390.4%-199.7%-1166.8%-6420.8%-11346.0%-12532.5%-19207.1%
Interest$0$0$0$0$0$0$0$0$0$0$0$0
Profit Before Tax$-13.0M$-14.0M$-29.0M$-31.0M$-29.0M$-41.0M$-45.0M$-59.0M$-60.0M$-67.0M$-85.0M$-94.0M
Tax$0$-590,000$0$0$0$-220,000$0$-160,000$0$280,000$-60,000$0
Net Profit$-13.0M$-14.0M$-29.0M$-31.0M$-29.0M$-41.0M$-45.0M$-59.0M$-60.0M$-68.0M$-85.0M$-94.0M
EPS$-0.33$-0.33$-0.55$-0.58$-0.54$-0.64$-0.65$-0.85$-0.85$-0.81$-0.99$-1.09

Over the 10 years reported for EyePoint, Inc., cash stood at $102.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 8.89 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$19.0M$19.0M$78.0M$73.0M$92.0M$263.0M$180.0M$355.0M$418.0M$364.0M
Current Assets$18.0M$18.0M$48.0M$42.0M$63.0M$238.0M$173.0M$345.0M$383.0M$329.0M
Cash$17.0M$17.0M$45.0M$22.0M$45.0M$179.0M$96.0M$281.0M$100.0M$102.0M
Inventory$0$0$0$2.0M$5.0M$4.0M$3.0M$4.0M$2.0M$2.0M
Receivables$0$0$1.0M$11.0M$9.0M$18.0M$16.0M$1.0M$1.0M$1.0M
Fixed Assets$0$0$0$3.0M$3.0M$3.0M$7.0M$10.0M$29.0M$20.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$6.0M$0$0$0$0$33.0M$49.0M$50.0M$271.0M$204.0M
Other Assets$0$0$0$0$0$0$0$0$0$0
Total Liabilities$5.0M$5.0M$60.0M$65.0M$73.0M$79.0M$84.0M$89.0M$82.0M$58.0M
Current Liabilities$5.0M$5.0M$21.0M$12.0M$15.0M$24.0M$35.0M$63.0M$49.0M$37.0M
Borrowings$0$17.0M$17.0M$51.0M$41.0M$39.0M$46.0M$5.0M$22.0M$23.0M
Other Liabilities$5.0M$0$43.0M$14.0M$32.0M$40.0M$38.0M$84.0M$60.0M$35.0M
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$13.0M$12.0M$38.0M$8.0M$19.0M$184.0M$96.0M$266.0M$337.0M$306.0M

For EyePoint, Inc., operating cash flow was positive in 1 of 10 reported years; free cash flow in the latest year was negative at $243.0M; free cash flow was positive in 0 of 10 years; financing activities used $1.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$-16.0M$-20.0M$-22.0M$-57.0M$-14.0M$-50.0M$-65.0M$2.0M$-126.0M$-240.0M
Investing Cash Flow$13.0M$-17.0M$-17.0M$0$-1.0M$-33.0M$-19.0M$-7.0M$-223.0M$65.0M
Financing Cash Flow$0$-53.0M$-20.0M$-19.0M$-1.0M$0$-3.0M$1.0M$1.0M$-1.0M
Net Cash Flow$-4.0M$2.0M$22.0M$-23.0M$23.0M$134.0M$-83.0M$186.0M$-182.0M$2.0M
Free Cash Flow$-16.0M$-21.0M$-22.0M$-57.0M$-15.0M$-50.0M$-67.0M$-2.0M$-130.0M$-243.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.03
EV / EBITDA-0.67
FCF Yield-94.61%
Quick Ratio4.46
Interest Coverage—
Return 1Y16.54%
Return 3Y18.99%
Return 5Y79.95%

EyePoint, Inc. (EYPT) financials — frequently asked questions

What is EyePoint, Inc.'s annual revenue?

EyePoint, Inc. (EYPT) reported annual revenue of $31.0M in its most recent fiscal year.

What is EyePoint, Inc.'s net profit?

EyePoint, Inc. (EYPT) reported a net loss of $232.0M in its most recent fiscal year.

What is EYPT EV/EBITDA?

EyePoint, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -0.67. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
EYPT Overview EYPT Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.